Melanoma brain metastases: review of histopathological features and immune-molecular aspects

por Salvati, Lorenzo, Mandalà, Mario, Massi, Daniela
Publicado 2020

Response to: Association of selected (immune-related) adverse events and outcome in two adjuvant phase III trials, Checkmate-238 and EORTC1325/KEYNOTE-054 by Eggermont et al

por Weber, Jeffrey, Mandala, Mario, Ascierto, Paolo Antonio, Larkin, James
Publicado 2022

Optimizing use of opiates in the management of cancer pain

por Mandalà, Mario, Moro, Cecilia, Labianca, Roberto, Cremonesi, Marco, Barni, Sandro
Publicado 2006

Impact of Circulating and Tissue Biomarkers in Adjuvant and Neoadjuvant Therapy for High-Risk Melanoma: Ready for Prime Time?

por Indini, Alice, Roila, Fausto, Grossi, Francesco, Massi, Daniela, Mandalà, Mario
Publicado 2021

Metabolic Interplay between the Immune System and Melanoma Cells: Therapeutic Implications

por Indini, Alice, Grossi, Francesco, Mandalà, Mario, Taverna, Daniela, Audrito, Valentina
Publicado 2021

Molecular Profiling and Novel Therapeutic Strategies for Mucosal Melanoma: A Comprehensive Review

por Indini, Alice, Roila, Fausto, Grossi, Francesco, Massi, Daniela, Mandalà, Mario
Publicado 2021

DOACs in patients with brain cancers: promising but still a long way to go

por Giustozzi, Michela, Becattini, Cecilia, Roila, Fausto, Agnelli, Giancarlo, Mandalà, Mario
Publicado 2022

Molecular Pathways in Melanomagenesis: What We Learned from Next-Generation Sequencing Approaches

por Palmieri, Giuseppe, Colombino, Maria, Casula, Milena, Manca, Antonella, Mandalà, Mario, Cossu, Antonio
Publicado 2018

ICH in primary or metastatic brain cancer patients with or without anticoagulant treatment: a systematic review and meta-analysis

por Giustozzi, Michela, Proietti, Giulia, Becattini, Cecilia, Roila, Fausto, Agnelli, Giancarlo, Mandalà, Mario
Publicado 2022

AKT-ions with a TWIST between EMT and MET

por Tang, Huifang, Massi, Daniela, Hemmings, Brian A., Mandalà, Mario, Hu, Zhengqiang, Wicki, Andreas, Xue, Gongda
Publicado 2016

Differential HLA class I subunit (A, B, C heavy chain and β(2)-microglobulin) expression levels in normal tissues

por Ugolini, Filippo, Szumera-Ciećkiewicz, Anna, Baroni, Gianna, Nesi, Gabriella, Mandalà, Mario, Ferrone, Soldano, Massi, Daniela
Publicado 2022

Dabrafenib and Trametinib prolong coagulation through the inhibition of tissue factor in BRAF(v600e) mutated melanoma cells in vitro

por Scatena, Cristian, Franceschi, Sara, Franzini, Maria, Sanguinetti, Chiara, Romiti, Nadia, Caponi, Laura, Mandalà, Mario, Mazzanti, Chiara Maria, Naccarato, Antonio Giuseppe
Publicado 2019

Chemotherapy-associated thromboembolic risk in cancer outpatients and effect of nadroparin thromboprophylaxis: results of a retrospective analysis of the PROTECHT study

por Barni, Sandro, Labianca, Roberto, Agnelli, Giancarlo, Bonizzoni, Erminio, Verso, Melina, Mandalà, Mario, Brighenti, Matteo, Petrelli, Fausto, Bianchini, Carlo, Perrone, Tania, Gasparini, Giampietro
Publicado 2011

Digital Immunophenotyping Predicts Disease Free and Overall Survival in Early Stage Melanoma Patients

por De Logu, Francesco, Galli, Francesca, Nassini, Romina, Ugolini, Filippo, Simi, Sara, Cossa, Mara, Miracco, Clelia, Gianatti, Andrea, De Giorgi, Vincenzo, Rulli, Eliana, Cossu, Antonio, Massi, Daniela, Mandalà, Mario
Publicado 2021

The Analysis of Trends in Survival for Patients with Melanoma Brain Metastases with Introduction of Novel Therapeutic Options before the Era of Combined Immunotherapy—Multicenter I...

por Placzke, Joanna, Teterycz, Paweł, Quaglino, Pietro, Cybulska-Stopa, Bozena, Tucci, Marco, Rubatto, Marco, Skora, Tomasz, Interno, Valeria, Rosinska, Magdalena, Borkowska, Aneta, Szumera-Cieckiewicz, Anna, Mandala, Mario, Rutkowski, Piotr
Publicado 2022

Extracellular nicotinamide phosphoribosyltransferase (eNAMPT) is a novel marker for patients with BRAF-mutated metastatic melanoma

por Audrito, Valentina, Managò, Antonella, Zamporlini, Federica, Rulli, Eliana, Gaudino, Federica, Madonna, Gabriele, D'Atri, Stefania, Antonini Cappellini, Gian Carlo, Ascierto, Paolo Antonio, Massi, Daniela, Raffaelli, Nadia, Mandalà, Mario, Deaglio, Silvia
Publicado 2018

Multimodal Treatment of Advanced Mucosal Melanoma in the Era of Modern Immunotherapy

por Teterycz, Pawel, Czarnecka, Anna M., Indini, Alice, Spałek, Mateusz J., Labianca, Alice, Rogala, Pawel, Cybulska-Stopa, Bożena, Quaglino, Pietro, Ricardi, Umberto, Badellino, Serena, Szumera-Ciećkiewicz, Anna, Falkowski, Slawomir, Mandala, Mario, Rutkowski, Piotr
Publicado 2020

Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective

por Ombra, Maria Neve, Paliogiannis, Panagiotis, Stucci, Luigia Stefania, Colombino, Maria, Casula, Milena, Sini, Maria Cristina, Manca, Antonella, Palomba, Grazia, Stanganelli, Ignazio, Mandalà, Mario, Gandini, Sara, Lissia, Amelia, Doneddu, Valentina, Cossu, Antonio, Palmieri, Giuseppe
Publicado 2019

Intratumoral Cellular Heterogeneity: Implications for Drug Resistance in Patients with Non-Small Cell Lung Cancer

por Gregorc, Vanesa, Lazzari, Chiara, Mandalá, Mario, Ippati, Stefania, Bulotta, Alessandra, Cangi, Maria Giulia, Khater, Abdelrahman, Viganò, Maria Grazia, Mirabile, Aurora, Pecciarini, Lorenza, Ogliari, Francesca Rita, Arrigoni, Gianluigi, Grassini, Greta, Veronesi, Giulia, Doglioni, Claudio
Publicado 2021

PD-L1 up-regulation in melanoma increases disease aggressiveness and is mediated through miR-17-5p

por Audrito, Valentina, Serra, Sara, Stingi, Aureliano, Orso, Francesca, Gaudino, Federica, Bologna, Cinzia, Neri, Francesco, Garaffo, Giulia, Nassini, Romina, Baroni, Gianna, Rulli, Eliana, Massi, Daniela, Oliviero, Salvatore, Piva, Roberto, Taverna, Daniela, Mandalà, Mario, Deaglio, Silvia
Publicado 2017